0001567619-21-018320.txt : 20211014 0001567619-21-018320.hdr.sgml : 20211014 20211014204019 ACCESSION NUMBER: 0001567619-21-018320 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211014 FILED AS OF DATE: 20211014 DATE AS OF CHANGE: 20211014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fu Tao CENTRAL INDEX KEY: 0001644888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 211324578 MAIL ADDRESS: STREET 1: 3175 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 doc1.xml FORM 4 X0306 4 2021-10-14 0 0001704292 Zai Lab Ltd ZLAB 0001644888 Fu Tao C/O ZAI LAB LIMITED 4560 JINKE ROAD, BLDG 1, 4TH FLOOR PUDONG, SHANGHAI F4 201210 CHINA 1 1 0 0 President & COO Ordinary Shares 187668 D Ordinary Shares 2021-10-14 4 S 0 3360 102.02 D 94140 I See footnote Ordinary Shares 2021-10-14 4 S 0 5240 102.90 D 88900 I See footnote Ordinary Shares 2021-10-14 4 S 0 1400 103.44 D 87500 I See footnote The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person's spouse, dated June 17, 2021, expires February 28, 2022 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Reflects a weighted average sale price of $102.02 per share, at prices ranging from $101.40 to $102.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $102.90 per share, at prices ranging from $102.42 to $103.38 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $103.44 per share, at prices ranging from $103.43 to $103.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Shares held by Reporting Person's spouse. /s/ Bruce A. Blefeld, Attorney-in-Fact 2021-10-14